Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1979 3
1980 2
1981 1
1984 1
1985 1
1986 1
1987 4
1988 1
1989 1
1990 4
1991 1
1992 1
1993 4
1994 14
1995 12
1996 14
1997 14
1998 7
1999 17
2000 21
2001 25
2002 33
2003 38
2004 36
2005 43
2006 56
2007 50
2008 27
2009 40
2010 46
2011 49
2012 43
2013 40
2014 36
2015 25
2016 29
2017 26
2018 45
2019 51
2020 47
2021 42
2022 46
2023 58
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

966 results

Results by year

Filters applied: . Clear all
Page 1
Understanding of interaction (subgroup) analysis in clinical trials.
Brankovic M, Kardys I, Steyerberg EW, Lemeshow S, Markovic M, Rizopoulos D, Boersma E. Brankovic M, et al. Among authors: boersma e. Eur J Clin Invest. 2019 Aug;49(8):e13145. doi: 10.1111/eci.13145. Epub 2019 Jun 14. Eur J Clin Invest. 2019. PMID: 31135965 Review.
Telemonitoring for heart failure: a meta-analysis.
Scholte NTB, Gürgöze MT, Aydin D, Theuns DAMJ, Manintveld OC, Ronner E, Boersma E, de Boer RA, van der Boon RMA, Brugts JJ. Scholte NTB, et al. Among authors: boersma e. Eur Heart J. 2023 Aug 14;44(31):2911-2926. doi: 10.1093/eurheartj/ehad280. Eur Heart J. 2023. PMID: 37216272 Free PMC article.
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.
Head SJ, Milojevic M, Daemen J, Ahn JM, Boersma E, Christiansen EH, Domanski MJ, Farkouh ME, Flather M, Fuster V, Hlatky MA, Holm NR, Hueb WA, Kamalesh M, Kim YH, Mäkikallio T, Mohr FW, Papageorgiou G, Park SJ, Rodriguez AE, Sabik JF 3rd, Stables RH, Stone GW, Serruys PW, Kappetein AP. Head SJ, et al. Among authors: boersma e. Lancet. 2018 Mar 10;391(10124):939-948. doi: 10.1016/S0140-6736(18)30423-9. Epub 2018 Feb 23. Lancet. 2018. PMID: 29478841 Free article. Review.
Sex differences in cardiovascular risk factors and disease prevention.
Appelman Y, van Rijn BB, Ten Haaf ME, Boersma E, Peters SA. Appelman Y, et al. Among authors: boersma e. Atherosclerosis. 2015 Jul;241(1):211-8. doi: 10.1016/j.atherosclerosis.2015.01.027. Epub 2015 Jan 28. Atherosclerosis. 2015. PMID: 25670232 Review.
Carotid Plaque Characteristics Predict Recurrent Ischemic Stroke and TIA: The PARISK (Plaque At RISK) Study.
van Dam-Nolen DHK, Truijman MTB, van der Kolk AG, Liem MI, Schreuder FHBM, Boersma E, Daemen MJAP, Mess WH, van Oostenbrugge RJ, van der Steen AFW, Bos D, Koudstaal PJ, Nederkoorn PJ, Hendrikse J, van der Lugt A, Kooi ME; PARISK Study Group. van Dam-Nolen DHK, et al. Among authors: boersma e. JACC Cardiovasc Imaging. 2022 Oct;15(10):1715-1726. doi: 10.1016/j.jcmg.2022.04.003. Epub 2022 Jun 15. JACC Cardiovasc Imaging. 2022. PMID: 36202450 Free article.
Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial.
Diletti R, den Dekker WK, Bennett J, Schotborgh CE, van der Schaaf R, Sabaté M, Moreno R, Ameloot K, van Bommel R, Forlani D, van Reet B, Esposito G, Dirksen MT, Ruifrok WPT, Everaert BRC, Van Mieghem C, Elscot JJ, Cummins P, Lenzen M, Brugaletta S, Boersma E, Van Mieghem NM; BIOVASC Investigators. Diletti R, et al. Among authors: boersma e. Lancet. 2023 Apr 8;401(10383):1172-1182. doi: 10.1016/S0140-6736(23)00351-3. Epub 2023 Mar 5. Lancet. 2023. PMID: 36889333 Clinical Trial.
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Van Mieghem NM, Unverdorben M, Hengstenberg C, Möllmann H, Mehran R, López-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rodés-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD; ENVISAGE-TAVI AF Investigators. Van Mieghem NM, et al. Among authors: boersma e. N Engl J Med. 2021 Dec 2;385(23):2150-2160. doi: 10.1056/NEJMoa2111016. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449183 Clinical Trial.
Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial.
Brugts JJ, Radhoe SP, Clephas PRD, Aydin D, van Gent MWF, Szymanski MK, Rienstra M, van den Heuvel MH, da Fonseca CA, Linssen GCM, Borleffs CJW, Boersma E, Asselbergs FW, Mosterd A, Brunner-La Rocca HP, de Boer RA; MONITOR-HF investigators. Brugts JJ, et al. Among authors: boersma e. Lancet. 2023 Jun 24;401(10394):2113-2123. doi: 10.1016/S0140-6736(23)00923-6. Epub 2023 May 20. Lancet. 2023. PMID: 37220768 Clinical Trial.
Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC).
Roos-Hesselink J, Baris L, Johnson M, De Backer J, Otto C, Marelli A, Jondeau G, Budts W, Grewal J, Sliwa K, Parsonage W, Maggioni AP, van Hagen I, Vahanian A, Tavazzi L, Elkayam U, Boersma E, Hall R. Roos-Hesselink J, et al. Among authors: boersma e. Eur Heart J. 2019 Dec 14;40(47):3848-3855. doi: 10.1093/eurheartj/ehz136. Eur Heart J. 2019. PMID: 30907409 Free article.
The legacy of HOPE-3.
Boersma E, Kardys I. Boersma E, et al. Eur Heart J. 2021 Aug 17;42(31):3008-3010. doi: 10.1093/eurheartj/ehab208. Eur Heart J. 2021. PMID: 33956954 No abstract available.
966 results